| Rank | Pathway / Axis | Cancer Cells | Normal Cells | TSF | Primary Effect | Notes / Interpretation |
|---|---|---|---|---|---|---|
| 1 | Nrf2/ARE antioxidant response (Keap1-Nrf2-HO-1) | Stress adaptation modulation (context-dependent) | Nrf2 ↑; HO-1 & GSH systems ↑ | R, G | Endogenous antioxidant upshift | Hydroxycinnamic acids commonly promote Nrf2 nuclear translocation and elevate antioxidant defense enzymes; this is one of the most consistent in vivo correlates. |
| 2 | NF-κB inflammatory transcription | NF-κB ↓; pro-inflammatory cytokine programs ↓ (reported) | Inflammation tone ↓; protective in injury models | R, G | Anti-inflammatory signaling | Hydroxycinnamic acids are widely reported to reduce NF-κB activity and downstream cytokine expression across inflammation and tumor models. |
| 3 | ROS / oxidative stress modulation | Oxidative stress ↓ (often); ROS direction variable | Oxidative injury ↓ in stress models | P, R, G | Redox buffering (context-dependent) | These acids are generally antioxidant, but in certain cancer models or at higher concentrations they may affect redox dynamics differentially. |
| 4 | Cell-cycle checkpoints (Cyclin D1/CDK4/6; checkpoints) | Cell-cycle arrest ↑ (reported); Cyclin/CDKs ↓ | ↔ | G | Cytostasis | Largely late phenotype outcome linked to signaling changes. |
| 5 | Apoptosis (intrinsic/mitochondrial & caspase-linked) | Apoptosis ↑; caspase activation ↑ (reported) | ↔ (less activation in normal contexts) | G | Cell death execution | Dependent on model and oxidative stress context; not as “direct” as classical mitochondrial toxins. |
| 6 | MAPK re-wiring (ERK / JNK / p38) | MAPK modulation (context-dependent) | ↔ | P, R, G | Signal reprogramming | Directions vary by tissue, stress levels, and derivative; avoid fixed arrows for all MAPKs unless model-specific evidence is provided. |
| 7 | PI3K → AKT (± mTOR) survival axis | PI3K/AKT modulation (reported) | ↔ | R, G | Survival/growth modulation | Often reported as downstream of NF-κB suppression and redox buffering. |
| 8 | Invasion / metastasis programs (MMPs / EMT) | MMPs ↓; migration-invasion ↓ (reported) | ↔ | G | Anti-invasive phenotype | Observed as downstream phenotypes; direction depends on specific hydroxycinnamic acid derivative. |
| 9 | Angiogenesis signaling (VEGF & angiogenic outputs) | VEGF ↓; angiogenesis markers ↓ (reported) | ↔ | G | Anti-angiogenic support | Later phenotype marker; linked to reduced pro-inflammatory and survival signaling. |
| 10 | Bioavailability / metabolism constraint (conjugation; food matrix dependence) | Systemic exposure variable; rapid conjugation | — | — | Translation constraint | Hydroxycinnamic acids are absorbed but rapidly metabolized (phase II conjugates); food matrix alters bioaccessibility and systemic exposure. |
Time-Scale Flag (TSF): P / R / G